secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeyondSpring Inc. (BYSI)
CIK:        0001677940
Form:       8-K
Filed at:   2026-05-13T11:00:21+00:00
Accession:  0001171843-26-003344
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeyondSpring Q1 net loss $2.4M from continuing ops; cash $7.9M; AACR data supports Plinabulin-ADC combo
--------------------------------------------------------------------------------

- Net loss from continuing operations $2.4M vs $2.6M YoY; discontinued ops loss $4.3M.
- Cash and short-term investments $7.9M as of March 31, 2026.
- AACR 2026 data: Plinabulin enhances efficacy/tolerability of topoisomerase inhibitor–based ADC regimens.
- ST-01156 (RBM39 degrader) advanced to Phase 1; first dose cohort completed.
- SEED's operations reported as discontinued due to planned sale of preferred shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677940/000117184326003344/0001171843-26-003344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677940/000117184326003344/f8k_051326.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-003344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer